Bart Friedman - 12 Dec 2024 Form 4 Insider Report for Ovid Therapeutics Inc. (OVID)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OVID	Stock Option (Right to Buy)	Award	$0	+90,000		$0.000000	90,000	12 Dec 2024	Common Stock	90,000	$1.06	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The shares will vest in 36 equal monthly installments, subject to the Reporting Person's continued services through such date.